Dosing patterns of dulaglutide and semaglutide in patients with type 2 diabetes mellitus in France and Italy: a retrospective cohort study
Semaglutide is FDA-approved for weight management under the brand name Wegovy and is also the active ingredient in Ozempic, which is FDA-approved for diabetes but commonly prescribed off-label for weight loss
Contact our office today to schedule a consultation
Because of a lapsed administrative patent filing by Novo Nordisk, generic manufacturers like Sandoz have already filed for approval
Working with your doctor is still important That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, including gastrointestinal issues like nausea and diarrhea, and pancreatitis, an inflammation of the pancreas
Its not suitable for everyone, especially those with a history of seizures, eating disorders, or alcohol/substance abuse